Lior Alkalay

Lior Alkalay

InvestorPlace Contributor

Lior is a consummate professional; a passionate analyst and economist with comprehensive experience within the financial services sector. With nearly 10 years of experience in trading and investment, Lior has provided his clients with crisp, clear and thorough analysis. Before becoming an independent analyst, he was employed for several years as the director of sell-side research at a leading international broker.

Lior specializes in mid- to long-range stock and ETF analyses using an out-of-the-box investment approach. That approach includes top-down analysis to identify the most attractive sectors, and then he balances it with cherry-picking to find the best opportunities.

Recent Articles

AMZN Stock Hasn’t Done Anything for Investors Lately

By Lior Alkalay, InvestorPlace Contributor

AMZN stock is much too risky to own as net income remains barely positive and debt continues to rise.

Teva Pharmaceuticals (TEVA): The Best Long-Term Play in Pharma

By Lior Alkalay, InvestorPlace Contributor

Generic drugmaker Teva Pharmaceuticals has a drab but stable long-term business that makes TEVA stock a clear buy in the pharma industry.

Disney Stock: A Rare Discount Thanks to Earnings (DIS)

By Lior Alkalay, InvestorPlace Contributor

Deep discounts in Disney stock don't come along all that often, so buyers should take advantage of this quick souring on DIS shares.

Twitter Stock: Dorsey Unleashes the Ugly Truth

By Lior Alkalay, InvestorPlace Contributor

Twitter CEO Jack Dorsey delivered the ugly, unvarnished facts ... but Twitter stock holders needed to hear some solutions, too.

Twitter Earnings Preview: Does TWTR Stock Still Have Wings?

By Lior Alkalay, InvestorPlace Contributor

TWTR stock is set to release earnings today after the market closes. Investors should be looking for higher earnings and lower costs.

Load More